Here is a brief summary of global bioethics and Dell'Oro's papers. Global bioethics is blah blah blah blah blah blah Here is a brief summary of global bioethics and Dell'Oro's papers. Global bioethics is blah blah blah blah blah blah Here is a brief summary of global bioethics and Dell'Oro's papers. Global bioethics is blah blah blah blah blah blah
Here is a brief summary of global bioethics and Dell'Oro's papers. Global bioethics is blah blah blah blah blah blah Here is a brief summary of global bioethics and Dell'Oro's papers. Global bioethics is blah blah blah blah blah blah Here is a brief summary of global bioethics and Dell'Oro's papers. Global bioethics is blah blah blah blah blah blah
a resource of the Bioethics Institute of Loyola Marymount University
THE BIOETHICS HUB
AT THE BIOETHICS INSTITUTE
The Bioethics Hub is a resource for healthcare providers, bioethicists, scholars, and students in Southern California and beyond. There are academic articles, interviews with bioethicists, links to ethics-related news items, and local bioethics events.
This site is managed by the Bioethics Institute at Loyola Marymount University.
1024_1.jpg)
Advance Directives and Dementia Care
April 25, 2023 (LMU)
Over the last decade, there have been several controversial cases involving the authority of advance directives for persons with dementia, relating to voluntarily stopping eating and drinking (VSED) and euthanasia. At play are fundamental questions of who are and how we can respect human dignity. These cases highlight the need for a greater discussion surrounding care for persons with dementia, as we face an aging population.
To read more, click here
Rethinking Social Solidarity in a Global Context: Bioethics and Human Rights
March 21, 2023 (LMU)
On Tuesday March 21, esteemed bioethicist and international scholar, Dr. Henk ten Have gave a lecture to students, faculty, and the LMU community on social solidarity, vulnerability, and human rights in a global context. Following the lecture, he, along with Professor Roberto Dell'Oro, answered questions from the audience.
To read more about the lecture, click here.
Professor Roberto Dell'Oro appointed as Ordinary Member of Pontifical Academy for Life, Meets Pope Francis
February 2, 2023 (LMU)
In February, Dr. Dell'Oro had the honor of meeting with the Pope following his appointment as an Ordinary Member of the Pontifical Academy for Life.
To read more, click here.
SPOTLIGHT
This section features interviews with and narratives of Southern California bioethicists as well as students and faculty of the LMU Bioethics Institute.
NATIONAL AND GLOBAL BIOETHICS NEWS, SCHOLARSHIP, AND ISSUES
CATHOLIC UNIVERSITY
OF VALENCIA
The Observatory is a monthly collection of special reports and news based on the latest biomedical and biotechnological research findings from the top medical and scientific journals.
BIOETHICS IN ACADEMIC LITERATURE
The Johns Hopkins weekly roundup is a compilation of bioethical research in global academic literature.
Elon Musk’s brain implant company Neuralink says it has US approval to begin trials in people
May 26, 2023
(AP News)
Elon Musk’s brain implant company Neuralink says it’s gotten permission from U.S. regulators to begin testing its device in people.
ADVERTISEMENT
The company made the announcement on Twitter Thursday evening but has provided no details about a potential study, which was not listed on the U.S. government database of clinical trials.
Read the article here.
Oregon, awash in treatment funds after decriminalizing drugs, now must follow the money
May 26, 2023
(AP News)
Funding for drug treatment centers in Oregon, financed by the state’s pioneering drug decriminalization policy, stood at over a quarter-billion dollars Friday as officials called for closer monitoring of where the money goes.
That need for oversight was demonstrated Wednesday when state officials terminated a $1.5 million grant agreement with a drug recovery nonprofit in Klamath Falls accused of failing to submit completed expenditure and data reports and buying a building for more than double the authorized amount.